Literature DB >> 30186493

Tumor suppressor function of miR-483-3p on breast cancer via targeting of the cyclin E1 gene.

Xiaoxi Huang1, Jin Lyu2.   

Abstract

microRNA (miR)-483-3p has previously been demonstrated to be a tumor suppressor in many types of cancer cells, however it is unknown whether miR-483-3p is involved in the regulation of breast cancer. Therefore, the aim of the present study was to investigate the effects of miR-483-3p on breast cancer. The results demonstrated that the expression of miR-483-3p was decreased, especially in MCF-7 cells. The results of CCK-8 assay and cell cycle analysis demonstrated that miR-483-3p significantly reduced cell proliferation and inhibited MCF-7 cells in the G1 phase from entering the S phase (P<0.01). It was also demonstrated that Cyclin E1 (CCNE1) is a target gene of miR-483-3p using bioinformatics and a dual luciferase reporter assay. miR-483-3p inhibited the expression of CCNE1, cyclin-dependent kinase 2, nuclear protein ataxia-telangiectasia (NPAT) and phosphorylated NPAT. Therefore, the results indicated that miR-483-3p functions as a tumor suppression in breast cancer and CCNE1 is its target gene. Downstream genes of CCNE1 were also repressed by miR-483-3p. Therefore, these findings suggest that miR-483-3p is a key factor in breast cancer.

Entities:  

Keywords:  breast cancer; cell cycle; cyclin E1; microRNA-483-3p; proliferation

Year:  2018        PMID: 30186493      PMCID: PMC6122499          DOI: 10.3892/etm.2018.6504

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Oncogenic role of miR-483-3p at the IGF2/483 locus.

Authors:  Angelo Veronese; Laura Lupini; Jessica Consiglio; Rosa Visone; Manuela Ferracin; Francesca Fornari; Nicola Zanesi; Hansjuerg Alder; Gemma D'Elia; Laura Gramantieri; Luigi Bolondi; Giovanni Lanza; Patrizia Querzoli; Adriano Angioni; Carlo M Croce; Massimo Negrini
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

3.  Breast-cancer awareness in low-income countries.

Authors:  Eugenio Panieri
Journal:  Lancet Oncol       Date:  2013-01-31       Impact factor: 41.316

4.  MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.

Authors:  Jun Hao; Shuyu Zhang; Yingqi Zhou; Xiangui Hu; Chenghao Shao
Journal:  FEBS Lett       Date:  2010-11-27       Impact factor: 4.124

5.  miR-483-3p regulates hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice.

Authors:  Yu Qiao; Yanli Zhao; Yan Liu; Ning Ma; Chuxuan Wang; Jiaqi Zou; Zhiyan Liu; Zhongqiu Zhou; Dong Han; Jun He; Qian Sun; Yicong Liu; Changqing Xu; Zhimin Du; Hui Huang
Journal:  Biochem Biophys Res Commun       Date:  2016-06-23       Impact factor: 3.575

6.  Redundant cyclin overexpression and gene amplification in breast cancer cells.

Authors:  K Keyomarsi; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

Review 7.  Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.

Authors:  F Asghari; N Haghnavaz; B Baradaran; M Hemmatzadeh; T Kazemi
Journal:  Biomed Pharmacother       Date:  2016-04-23       Impact factor: 6.529

8.  Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17.

Authors:  Min Deng; Fahui Li; Bryan A Ballif; Shan Li; Xi Chen; Lin Guo; Xin Ye
Journal:  J Biol Chem       Date:  2009-01-16       Impact factor: 5.157

9.  Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.

Authors:  Ji-Yuan Han; Hui Wang; Yun-Tao Xie; Yan Li; Li-Yuan Zheng; Yuan Ruan; Ai-Ping Song; Xin-Xia Tian; Wei-Gang Fang
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Differential expression of genes involved in the epigenetic regulation of cell identity in normal human mammary cell commitment and differentiation.

Authors:  Danila Coradini; Patrizia Boracchi; Saro Oriana; Elia Biganzoli; Federico Ambrogi
Journal:  Chin J Cancer       Date:  2014-09-16
View more
  11 in total

Review 1.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

2.  Medulloblastoma malignant biological behaviors are associated with HOTAIR/miR-483-3p/CDK4 axis.

Authors:  Long Zhao; Tao Chen; Xiaoping Tang; Shun Li; Ruofei Liang; Yuanchuan Wang
Journal:  Ann Transl Med       Date:  2020-07

Review 3.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

4.  An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.

Authors:  Jianing Tang; Qiuxia Cui; Dan Zhang; Xing Liao; Jian Zhu; Gaosong Wu
Journal:  J Cell Mol Med       Date:  2019-05-23       Impact factor: 5.310

5.  circZNF609 promotes the proliferation and migration of gastric cancer by sponging miR-483-3p and regulating CDK6.

Authors:  Weidong Wu; Ningxian Wei; Gang Shao; Chunnan Jiang; Shaoru Zhang; Lihui Wang
Journal:  Onco Targets Ther       Date:  2019-10-04       Impact factor: 4.147

Review 6.  MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.

Authors:  Mohammad Mijanur Rahman; Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

Review 7.  The Regulatory Role of MicroRNAs in Breast Cancer.

Authors:  Hui-Yi Loh; Brendan P Norman; Kok-Song Lai; Nik Mohd Afizan Nik Abd Rahman; Noorjahan Banu Mohamed Alitheen; Mohd Azuraidi Osman
Journal:  Int J Mol Sci       Date:  2019-10-06       Impact factor: 5.923

8.  The lncRNA NEAT1 promotes the epithelial-mesenchymal transition and metastasis of osteosarcoma cells by sponging miR-483 to upregulate STAT3 expression.

Authors:  Yan Chen; Jun Li; Jia-Kun Xiao; Lei Xiao; Bin-Wu Xu; Chen Li
Journal:  Cancer Cell Int       Date:  2021-02-05       Impact factor: 5.722

9.  Remifentanil repairs cartilage damage and reduces the degradation of cartilage matrix in post-traumatic osteoarthritis, and inhibits IL-1β-induced apoptosis of articular chondrocytes via inhibition of PI3K/AKT/NF-κB phosphorylation.

Authors:  Hai Ke; Xiaping Mou; Qing Xia
Journal:  Ann Transl Med       Date:  2020-11

10.  Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma.

Authors:  Di Cao; Xia Cao; Yu Jiang; Juan Xu; Yuhuan Zheng; Deying Kang; Caigang Xu
Journal:  Hematol Oncol       Date:  2021-12-17       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.